Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

Eribulin Impurity 1

Eribulin Impurity 1 is listed in the pharmaceutical impurity collection under CAS 185411-12-5. Its represented structure has formula C9H18O2Si and a calculated molecular weight of 186.33 g/mol.

2D chemical structure

O O S i

Chemical identity

Catalog name
Eribulin Impurity 1
Common name
Eribulin Impurity 1
Chemical name
methyl 3-trimethylsilylpent-4-enoate
CAS
185411-12-5
SMILES
C=CC(CC(=O)OC)[Si](C)(C)C
InChI
InChI=1S/C9H18O2Si/c1-6-8(12(3,4)5)7-9(10)11-2/h6,8H,1,7H2,2-5H3
InChIKey
DJXDHDYQDMVTPZ-UHFFFAOYSA-N
Associated API
Eribulin

Record ID: Af8ae758467c3

Computed properties

C9H18O2Si Molecular formula
186.327 g/molMolecular weight
186.1076 DaMonoisotopic exact mass
26.3 ŲTopological polar surface area
2.4439 Calculated LogP (Wildman–Crippen)
53.926 cm³/molMolar refractivity (Wildman–Crippen)
2 countHydrogen-bond acceptors
0 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD. 1 potential atom stereocenters have unspecified configuration.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H O Si 0 4 8 12 16 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight186.32714.09
Calculated LogP (Wildman–Crippen)2.443951.18
Topological polar surface area26.310.80
Hydrogen-bond acceptors215.92
Hydrogen-bond donors011.28
Rotatable bonds (strict)449.39

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC9H18O2Sidimensionless
Molecular weight186.327g/mol
Monoisotopic exact mass186.1076Da
Topological polar surface area26.3Ų
Calculated LogP (Wildman–Crippen)2.4439dimensionless
Molar refractivity (Wildman–Crippen)53.926cm³/mol
Hydrogen-bond acceptors2count
Hydrogen-bond donors0count
Rotatable bonds (strict)4count
Heavy atoms12count
Heteroatoms3count
Rings0count
Aromatic rings0count
Aliphatic rings0count
Saturated rings0count
Aromatic heterocycles0count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles0count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.6667fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters1count
Unspecified atom stereocenters1count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area75.6252Ų
Valence electrons70count
Radical electrons0count
Bertz complexity169.8576index
Balaban J4.1879index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Eribulin Impurity 1

Qualification and safety assessment of Eribulin Impurity 1

Explore toxicological qualification of Eribulin Impurity 1 and ICH M7 mutagenic impurity assessment of Eribulin Impurity 1 for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for Eribulin Impurity 1 and acceptable intake and limit justification for Eribulin Impurity 1. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Eribulin Impurity 1

Explore Altox services and software through the Altox Pharma-Hub.